The Application of Dendritic Cell-derived Exomes in Tumour Immunotherapy
Cancer arises from the aberrant proliferation of a single transformed cell. This population acquires the ability to metastasise. An effective way to remove cancer cells from the body is to activate tumour-specific cytotoxic T cells (CTL). Activation of naive T cells depends on the unique antigen presenting capacity of DC. Activated tumour antigen-specific CTL can destroy cancer cells without harm to normal tissue. Their ability to stimulate antigen specific T cell responses makes DC attractive...[Show more]
|Collections||ANU Research Publications|
|Source:||Cancer Biotherapy and Radiopharmaceuticals|
|01_Quah_The_Application_of_Dendritic_2000.pdf||5.2 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.